Search Results - "Rangel, Érika B."

Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes Mellitus, Obesity and Diabetic Kidney Disease by Bastos, Rosana M C, Simplício-Filho, Antônio, Sávio-Silva, Christian, Oliveira, Luiz Felipe V, Cruz, Giuliano N F, Sousa, Eliza H, Noronha, Irene L, Mangueira, Cristóvão L P, Quaglierini-Ribeiro, Heloísa, Josefi-Rocha, Gleice R, Rangel, Érika B

“…Diabetes mellitus (DM) burden encompasses diabetic kidney disease (DKD), the leading cause of end-stage renal disease worldwide. Despite compelling evidence…”
Get full text

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies by Rangel, Érika B., Rodrigues, Cláudia O., de Sá, João R.

“…Collectively, gender differences may be taken into account when providing healthcare management and allocate resources for prevention and treatment of…”
Get full text

Progenitor/Stem Cell Delivery by Suprarenal Aorta Route in Acute Kidney Injury by Rangel, Érika B., Gomes, Samirah A., Kanashiro-Takeuchi, Rosemeire, Hare, Joshua M.

“…Progenitor/stem cell-based kidney regenerative strategies are a key step towards the development of novel therapeutic regimens for kidney disease treatment…”
Get full text

Impact of Hypertension on COVID-19 Burden in Kidney Transplant Recipients: An Observational Cohort Study by Aguiar-Brito, Isabella, de Lucena, Débora D, Veronese-Araújo, Alexandre, Cristelli, Marina P, Tedesco-Silva, Hélio, Medina-Pestana, José O, Rangel, Érika B

“…COVID-19 severity is determined by cardiometabolic risk factors, which can be further aggravated by chronic immunosuppression in kidney transplant recipients…”
Get full text

COVID-19 in Kidney Transplant Recipients With Diabetes Mellitus: A Propensity Score Matching Analysis by Rangel, Érika B., de Lucena, Débora D., Aguiar-Brito, Isabella, de Andrade, Luís Gustavo Modelli, Veronese-Araújo, Alexandre, Cristelli, Marina P., Tedesco-Silva, Hélio, Medina-Pestana, José O.

“…Kidney transplant recipients present higher rates of pre-existing comorbidities, in particular diabetes mellitus (DM), hypertension, and cardiac disease. We…”
Get full text

The effects of a short-term meditation-based mindfulness protocol in patients receiving hemodialysis by Igarashi, Nadja S., Karam, Christiane H., Afonso, Rui F., Carneiro, Fabiana D., Lacerda, Shirley S., Santos, Bento F., Kozasa, Elisa H., Rangel, Érika B.

“…Mindfulness-based approaches that promote health, improve quality of life, and reduce the impact of comorbidities are key aspects in chronic diseases…”
Get full text

Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells by Rangel, Érika B., Simplício-Filho, Antônio, Balby-Rocha, Maria Theresa A., Casaro, Expedito B., Soinski-Sousa, Poliana E., Beyerstedt, Stephany, Sávio-Silva, Christian, Alves-Silva, Jamille

“…Diabetic kidney disease (DKD) is a microvascular complication of diabetes mellitus (DM) and comprises multifactorial pathophysiologic mechanisms. Despite…”
Get full text

Sex Differences among Overweight/Obese Kidney Transplant Recipients Requiring Oxygen Support Amid the COVID-19 Pandemic by Veronese-Araújo, Alexandre, de Lucena, Débora D, Aguiar-Brito, Isabella, Cristelli, Marina P, Tedesco-Silva, Hélio, Medina-Pestana, José O, Rangel, Érika B

“…Background and Objectives: Overweight/obesity puts individuals at greater risk for COVID-19 progression and mortality. We aimed to evaluate the impact of…”
Get full text

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy by Gomes, Samirah A., Bastos, Rosana M. C., Higuti, Eliza, Paulini, Janaina, Rangel, Érika B.

“…Mesenchymal stem cells (MSCs) possess pleiotropic properties that include immunomodulation, inhibition of apoptosis, fibrosis and oxidative stress, secretion…”
Get full text

Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study by Bezinelli, Leticia M, Corrêa, Luciana, Beyerstedt, Stephany, Franco, Marcella L, Rangel, Érika B, Benítez, Carlos Guillermo, Hamerschlak, Nelson, Pinho, João R R, Heller, Debora, Eduardo, Fernanda P

“…Symptomatic patients with COVID-19 typically have a high SARS-CoV-2 viral load in their saliva. Procedures to reduce the viral load in their oral cavity are…”
Get full text

Stem Cell Applications in Regenerative Medicine for Kidney Diseases by Rangel, Érika B., Rodrigues, Cláudia O., Guimarães-Souza, Nádia K.

“…Overall, CKD is mainly caused by diabetic kidney disease (DKD), hypertension, and glomerulonephritis. [...]the search for nonpharmacological strategies for…”
Get full text

mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions by Fernandes-Silva, Gabriel, Ivani de Paula, Mayara, Rangel, Érika B

“…Patient and pancreas allograft survival improved following reductions in surgical complications, tighter donor selection and optimization in immunosuppressive…”
Get more information

Excessive cholecalciferol supplementation increases kidney dysfunction associated with intrarenal artery calcification in obese insulin-resistant mice by Almeida, Youri E., Fessel, Melissa R., do Carmo, Luciana Simão, Jorgetti, Vanda, Farias-Silva, Elisângela, Pescatore, Luciana Alves, Gamarra, Lionel F., Andrade, Maria Claudina, Simplicio-Filho, Antonio, Mangueira, Cristóvão Luis Pitangueiras, Rangel, Érika B., Liberman, Marcel

“…Diabetes mellitus accelerates vascular calcification (VC) and increases the risk of end-stage renal disease (ESRD). Nevertheless, the impact of VC in renal…”
Get full text

Late Conversion to Sirolimus or Everolimus After Pancreas Transplant by Marcella-Neto, Rubens, de Sá, João R., Melaragno, Cláudio S., Gonzalez, Adriano M., Salzedas-Neto, Alcides, Linhares, Marcelo M., Medina-Pestana, José O., Rangel, Érika B.

“…Pancreas transplant is an effective treatment for insulin-dependent diabetic individuals with end-stage renal disease, yet immunosuppression-associated adverse…”
Get full text

Oxygen Requirement in Overweight/Obese Kidney Transplant Recipients with COVID-19: An Observational Cohort Study by Veronese-Araújo, Alexandre, de Lucena, Débora D, Aguiar-Brito, Isabella, Modelli de Andrade, Luís Gustavo, Cristelli, Marina P, Tedesco-Silva, Hélio, Medina-Pestana, José O, Rangel, Érika B

“…Obesity is one of the components of the cardiometabolic syndrome that contributes to COVID-19 progression and mortality. Immunosuppressed individuals are at…”
Get full text

Charcot Neuroarthropathy After Simultaneous Pancreas-Kidney Transplant by RANGEL, Erika B, SA, João R, GOMES, Samirah A, CARVALHO, Aluizio B, MELARAGNO, Cláudio S, GONZALEZ, Adriano M, LINHARES, Marcelo M, MEDINA-PESTANA, Jose O

“…Immunosuppressive regimen is associated with several metabolic adverse effects. Bone loss and fractures are frequent after transplantation and involve…”
Get full text

Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation by Rangel, Erika B, Malheiros, Denise M A C, de Castro, Maria Cristina Ribeiro, Antunes, Irina, Torres, Margareth A, Crescentini, Fábio, Genzini, Tércio, Perosa, Marcelo

“…Antibody-mediated rejection (AMR) requires specific diagnostic tools and treatment and is associated with lower graft survival. We prospectively screened C4d…”
Get more information

Labile Plasma Iron Generation After Intravenous Iron is Time-dependent and Transitory in Patients Undergoing Chronic Hemodialysis by Rangel, Érika B, Espósito, Breno P, Carneiro, Fabiana D, Mallet, Ana Cláudia, Matos, Ana Cristina C, Andreoli, Maria Cláudia C, Guimarães-Souza, Nádia K, Santos, Bento FC

“…Iron supplementation in hemodialysis patients is fundamental to erythropoiesis, but may cause harmful effects. We measured oxidative stress using labile plasma…”
Get full text

Gut microbiota-derived metabolites are novel targets for improving insulin resistance by Bastos, Rosana M C, Rangel, Érika B

“…The gut microbiota plays a key role in metabolic diseases. Gut-microbiota-derived metabolites are found in different dietary sources, including: Carbohydrate…”
Get full text

Hemoglobin and hematocrit at the end of hemodialysis: a better way to adjust erythropoietin dose? by Rangel, Érika B., Andreoli, Maria Claudia, Matos, Ana Cristina C., Guimarães-Souza, Nadia K., Mallet, Ana Cláudia, Carneiro, Fabiana D., Santos, Bento C.

“…A severe disadvantage of administration of recombinant human erythropoietin to hemodialysis patients has been reported. A significant correlation has been…”
Get full text